515 filings
Page 5 of 26
8-K
oar0c15 acbg
1 Nov 18
Other Events
9:30am
8-K
4vhtg3
16 Oct 18
Changes in Control of Registrant
4:05pm
8-K
atjlepa83x
12 Oct 18
Departure of Directors or Certain Officers
4:18pm
424B3
r7ufdd9tgsdiml46t
9 Oct 18
Prospectus supplement
4:16pm
8-K
ozdhheavo0cupa9qat1
28 Sep 18
Entry into a Material Definitive Agreement
4:00pm
424B3
9tdzqibggksnc1 cyymv
21 Sep 18
Prospectus supplement
4:16pm
8-K
ym18cli
7 Sep 18
Entry into a Material Definitive Agreement
12:00am
D
pxebmos8y
17 Aug 18
$5.14M in equity, sold $5.14M, 13 investors
4:42pm
8-K
acp9r 7op6i
3 Aug 18
Entry into a Material Definitive Agreement
9:30am
424B3
ly08cxo 8duh0aqqzqxs
3 Aug 18
Prospectus supplement
9:16am
8-K
im3 us6ps4
5 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
73rufrhw
14 May 18
GT Biopharma Announces DR. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
4:01pm
8-K
pi4f78p91krew
27 Apr 18
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
4:01pm
EFFECT
tc4is23l1a cdy2
22 Mar 18
Notice of effectiveness
12:00am
EFFECT
qpij pfqu
22 Mar 18
Notice of effectiveness
12:00am
CORRESP
k1mxnofbfhmef8192n9t
21 Mar 18
Correspondence with SEC
12:00am